Insiders who have reported open-market trades at the same companies as Christer Rosen. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Christer Rosen is a corporate insider, tracked as CEO and Chairman, Director of JUPITER NEUROSCIENCES, INC. (JUNS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Christer Rosen last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2025.
Has Christer Rosen been buying or selling stock?
Recorded transactions: 9 open-market purchases ($12K) and 0 open-market sales across all tracked filings.
Christer Rosen is CEO and Chairman, Director of JUPITER NEUROSCIENCES, INC. (JUNS). 3 SEC Form 4 filings on record going back to 2025, most recently on 5 June 2026. Most recent open-market trade: bought $3K of JUNS on 1 July 2025. Lifetime open-market purchases: $12K.
Recent transactions
11
The latest 11 SEC Form 4 transactions reported by Christer Rosen.
InsiderAlpha's records for Christer Rosen go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. The typical open-market purchase is $1K (9 buys totaling $12K). The largest single buy on record is $3K of JUNS in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
